Kopp Investment Advisors’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-21,975
Closed -$111K 65
2016
Q2
$111K Buy
21,975
+7,860
+56% +$42.1K 0.06% 62
2016
Q1
$76K Sell
14,115
-135
-0.9% -$798 0.04% 66
2015
Q4
$103K Sell
14,250
-26,160
-65% -$176K 0.05% 65
2015
Q3
$190K Buy
40,410
+1,325
+3% +$12.6K 0.1% 63
2015
Q2
$435K Buy
39,085
+2,290
+6% +$22.5K 0.19% 55
2015
Q1
$268K Buy
36,795
+19,585
+114% +$160K 0.12% 64
2014
Q4
$166K Buy
+17,210
New +$134K 0.08% 68

Other funds holding VCYT

Kopp Investment Advisors's VCYT Position: Q3 2016 in Review

Kopp Investment Advisors sold out of Veracyte (VCYT) in Q3 2016, closing a stake of 21,975 shares — an estimated $111K sold.

Kopp Investment Advisors first reported a position in VCYT in Q4 2014 and held it in 7 quarters. The position peaked at $435K in Q2 2015. 55 funds tracked by Wall St. Rank hold VCYT as of Q3 2016.

  • Kopp Investment Advisors reported no remaining Veracyte position as of Q3 2016 after selling out during the quarter.
  • Kopp Investment Advisors sold 21,975 Veracyte shares in Q3 2016, an estimated $111K.
  • Kopp Investment Advisors first reported a position in Veracyte in Q4 2014 and held it in 7 quarters.
  • Kopp Investment Advisors's Veracyte position peaked at $435K in Q2 2015.
  • 55 funds tracked by Wall St. Rank held Veracyte as of Q3 2016.

Based on Kopp Investment Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.